Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Oruka Therapeutics (HQ1.F) Q3 2025 Earnings
HQ1.F
11
Aug
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.38
-1.04
-0.7
-0.36
Details
Expected EPS
-0.42193199099999995
Actual EPS
-0.3960186
Surprise EPS
0.03
Surprise Percent
+6.14%
Description
Oruka Therapeutics (HQ1.F) has reported earnings of -0.3960186 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login